Psychometric outcome measures in beta-propeller protein-associated neurodegeneration (BPAN)
Francesco Gavazzi(Children's Hospital of Philadelphia), Laura Adang(Children's Hospital of Philadelphia), Nivedita Thakur(Montreal Children's Hospital), Kayla Muirhead(Children's Hospital of Philadelphia), Jacob McCann(Children's Hospital of Philadelphia), Ashley Moll(Children's Hospital of Philadelphia), Erin Prange(Children's Hospital of Philadelphia), Omar Sherbini(Children's Hospital of Philadelphia), Kim A. Anderson(Oregon State University), Samuel R. Pierce(Children's Hospital of Philadelphia), Jamie L. Fraser(Children's National), Laura Tochen(Children's National), Joseph Vithayathil, Kristin Cunningham(Children's Hospital of Philadelphia), Ingo Helbig(Schneider Electric (France)), Naomi Lewin(Children's Hospital of Philadelphia), Holly Dubbs
Cited by 14
Related Papers
Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals
|The American Journal of Human Genetics|2019|310
Janus Kinase Inhibition in the Aicardi–Goutières Syndrome
|New England Journal of Medicine|2020|201
Defining the phenotypic spectrum of <i>SLC6A1</i> mutations
|Epilepsia|2018|153
Loss-of-function HDAC8 mutations cause a phenotypic spectrum of Cornelia de Lange syndrome-like features, ocular hypertelorism, large fontanelle and X-linked inheritance
|Human Molecular Genetics|2014|151
Genetic and phenotypic spectrum associated with IFIH1 gain‐of‐function
|Human Mutation|2020|115